ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 29, 2004

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

ZD6474

DRUG

Paclitaxel

DRUG

Carboplatin

Trial Locations (34)

Unknown

Research Site, Concord

Research Site, Los Angeles

Research Site, Chicago

Research Site, Boston

Research Site, St Louis

Research Site, Providence

Research Site, Nashville

Research Site, Austin

Research Site, Houston

Research Site, Lubbock

Research Site, Norfolk

Research Site, Seattle

Research Site, Helsinki

Research Site, Turku

Research Site, Besançon

Research Site, Lille

Research Site, Strasbourg

Research Site, Essen

Research Site, Frankfurt

Research Site, Mainz

Research Site, Ulm

Research Site, Pune

Research Site, Milan

Research Site, Orbassano

Research Site, Cape Town

Research Site, Johannesburg

Research Site, Panorama

Research Site, Parkland

Research Site, Pretoria

Research Site, Barcelona

Research Site, Madrid

Research Site, Málaga

Research Site, Pamplona

Research Site, Chiang Mai

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00071188 - ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter